Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04606732 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CardioVascular Disease Progression and Prognosis in COVID-19

Study acronym: CVP-Covid19
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 27, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: details revised at 2 of 3 entriesv5
  2. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025
    • Publications: details revised at 2 of 3 entries
    v4
  3. Primary and study completion dates: Dec 31, 2021 to Dec 31, 2024
    • Site contact updated
    v3
  4. Primary completion date: Dec 31, 2020 to Dec 31, 2021
    • Study description expanded, about 9 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The CVP-COVID19 registry is both a retrospective and prospective study design in order to identify predictors of cardiovascular disease progression and mortality for COVID-19. The registry enrolls consecutive patients with positive microbiological tests for SARS-CoV-2 admitted to an academic hospital in northern Italy for worsening of COVID-19 symptoms. The study does not test any new diagnostic or therapeutic approach. Patients are treated according to good clinical practice. Patients characteristics, including medical history (with particular attention to cardiovascular and pneumological risk factors), features of physical examination, results laboratory and radiological tests and treatments (pre- and in-hospital) are related with patient outcome. Logistic analysis (univariate, multivariate and propensity) are performed in order to identify factors associated with disease progression. Primary endpoint: mortality.
Trial Details
NCT Number NCT04606732
Lead Sponsor University of Bologna
Conditions
(from sponsor)		 Covid19
Related terms Cardiovascular Diseases, COVID-19, Pneumonia, Viral
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov